BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 14604546)

  • 1. Monoclonal antibodies generated in carbonic anhydrase IX-deficient mice recognize different domains of tumour-associated hypoxia-induced carbonic anhydrase IX.
    Zat'ovicová M; Tarábková K; Svastová E; Gibadulinová A; Mucha V; Jakubícková L; Biesová Z; Rafajová M; Ortova Gut M; Parkkila S; Parkkila AK; Waheed A; Sly WS; Horak I; Pastorek J; Pastoreková S
    J Immunol Methods; 2003 Nov; 282(1-2):117-34. PubMed ID: 14604546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible expression of the mouse carbonic anhydrase IX demonstrated by new monoclonal antibodies.
    Takacova M; Barathova M; Hulikova A; Ohradanova A; Kopacek J; Parkkila S; Pastorek J; Pastorekova S; Zatovicova M
    Int J Oncol; 2007 Nov; 31(5):1103-10. PubMed ID: 17912436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma.
    Chrastina A; Závada J; Parkkila S; Kaluz S; Kaluzová M; Rajcáni J; Pastorek J; Pastoreková S
    Int J Cancer; 2003 Jul; 105(6):873-81. PubMed ID: 12767076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain.
    Zatovicova M; Jelenska L; Hulikova A; Csaderova L; Ditte Z; Ditte P; Goliasova T; Pastorek J; Pastorekova S
    Curr Pharm Des; 2010; 16(29):3255-63. PubMed ID: 20819068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours.
    Ahlskog JK; Schliemann C; Mårlind J; Qureshi U; Ammar A; Pedley RB; Neri D
    Br J Cancer; 2009 Aug; 101(4):645-57. PubMed ID: 19623173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase IX (CA IX) mediates tumor cell interactions with microenvironment.
    Zavadova Z; Zavada J
    Oncol Rep; 2005 May; 13(5):977-82. PubMed ID: 15809767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Monoclonal Antibodies for a Selective Detection of Membrane-Associated and Soluble Forms of Carbonic Anhydrase IX in Human Cell Lines and Biological Samples.
    Stravinskiene D; Imbrasaite A; Petrikaite V; Matulis D; Matuliene J; Zvirbliene A
    Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31349673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use.
    Pastorek J; Pastorekova S
    Semin Cancer Biol; 2015 Apr; 31():52-64. PubMed ID: 25117006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of antibody structure upon association to a human carbonic anhydrase IX epitope studied by X-ray crystallography, microcalorimetry, and molecular dynamics simulations.
    Král V; Mader P; Collard R; Fábry M; Horejsí M; Rezácová P; Kozísek M; Závada J; Sedlácek J; Rulísek L; Brynda J
    Proteins; 2008 May; 71(3):1275-87. PubMed ID: 18041760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies raised against 167-180 aa sequence of human carbonic anhydrase XII inhibit its enzymatic activity.
    Dekaminaviciute D; Kairys V; Zilnyte M; Petrikaite V; Jogaite V; Matuliene J; Gudleviciene Z; Vullo D; Supuran CT; Zvirbliene A
    J Enzyme Inhib Med Chem; 2014 Dec; 29(6):804-10. PubMed ID: 24400872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique epitope-antibody interactions in the intrinsically disordered proteoglycan-like domain of human carbonic anhydrase IX defined by high-resolution NMR combined with yeast surface display.
    Ni F; Wu C; Xu P; Wang P; Fortin Y; Arbour M; Masson L; L'Abbé D; Acel A; Gosselin M; Lenferink AEG
    MAbs; 2023; 15(1):2248672. PubMed ID: 37622732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody G250 targeting CA Ⅸ: Binding specificity, internalization and therapeutic effects in a non-renal cancer model.
    Zatovicova M; Jelenska L; Hulikova A; Ditte P; Ditte Z; Csaderova L; Svastova E; Schmalix W; Boettger V; Bevan P; Pastorek J; Pastorekova S
    Int J Oncol; 2014 Dec; 45(6):2455-67. PubMed ID: 25230982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody.
    Chrastina A; Pastoreková S; Pastorek J
    Neoplasma; 2003; 50(1):13-21. PubMed ID: 12687273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase IX as a target for designing novel anticancer drugs.
    Monti SM; Supuran CT; De Simone G
    Curr Med Chem; 2012; 19(6):821-30. PubMed ID: 22214452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique biological properties of catalytic domain directed human anti-CAIX antibodies discovered through phage-display technology.
    Xu C; Lo A; Yammanuru A; Tallarico AS; Brady K; Murakami A; Barteneva N; Zhu Q; Marasco WA
    PLoS One; 2010 Mar; 5(3):e9625. PubMed ID: 20224781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient Expression and Crystallization System of Cancer-Associated Carbonic Anhydrase Isoform IX.
    Leitans J; Kazaks A; Balode A; Ivanova J; Zalubovskis R; Supuran CT; Tars K
    J Med Chem; 2015 Nov; 58(22):9004-9. PubMed ID: 26522624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target.
    De Simone G; Supuran CT
    Biochim Biophys Acta; 2010 Feb; 1804(2):404-9. PubMed ID: 19679200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical Characterization of Cancer-Related Carbonic Anhydrase IX.
    Koruza K; Murray AB; Mahon BP; Hopkins JB; Knecht W; McKenna R; Fisher SZ
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX.
    Alterio V; Hilvo M; Di Fiore A; Supuran CT; Pan P; Parkkila S; Scaloni A; Pastorek J; Pastorekova S; Pedone C; Scozzafava A; Monti SM; De Simone G
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16233-8. PubMed ID: 19805286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-specific detection of CAIX in breast and prostate cancers.
    Li Y; Wang H; Oosterwijk E; Selman Y; Mira JC; Medrano T; Shiverick KT; Frost SC
    Biochem Biophys Res Commun; 2009 Aug; 386(3):488-92. PubMed ID: 19538935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.